Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 8,408 $ 6,816
Restricted cash 250
Marketable debt securities, available for sale 8,779 1,639
Marketable equity securities, at fair value 76
Accounts receivable, net 37,708 3,155
Inventory, net 4,600 3,039
Prepaid expenses and other current assets 1,496 1,238
Total current assets 61,317 15,887
Property, plant and equipment, net 5,947 3,578
Secured promissory note receivable 2,750
Prepaid expenses, net of current portion 460 2,084
Right-of-use asset, net 4,402 4,731
Intangible assets, net 10,852 1,234
Goodwill 5,709 901
Other assets 608 240
TOTAL ASSETS 89,295 31,405
Current liabilities    
Accounts payable 7,026 3,771
Accrued diagnostic services 1,890
Accrued advertising and other allowances 104 463
Lease liabilities 663 329
Deferred revenue 2,034 169
Other current liabilities 3,807 1,562
Total current liabilities 15,524 6,294
Non-current liabilities:    
Deferred revenue, net of current portion 905 162
Note payable 44
Unsecured convertible promissory notes, net 9,996 9,991
Lease liabilities, net of current portion 4,198 4,402
Total non-current liabilities 15,143 14,555
Total liabilities 30,667 20,849
COMMITMENTS AND CONTINGENCIES  
Stockholders’ equity    
Preferred stock authorized 1,000,000, $0.0005 par value, no shares issued and outstanding
Common stock authorized 50,000,000, $0.0005 par value, 15,485,900 and 11,604,253 shares outstanding, respectively 16 14
Additional paid-in capital 104,552 61,674
Retained earnings (accumulated deficit) 2,642 (3,631)
Treasury stock, at cost, 16,818,846 and 16,652,022 shares, respectively (48,407) (47,490)
Accumulated other comprehensive loss (175) (11)
Total stockholders’ equity 58,628 10,556
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 89,295 $ 31,405